SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-001785
Filing Date
2015-01-05
Accepted
2015-01-05 16:28:35
Documents
10
Period of Report
2014-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d845399d8k.htm 8-K 16042
2 EX-10.1 d845399dex101.htm EX-10.1 77468
3 EX-99.1 d845399dex991.htm EX-99.1 243575
4 EX-99.2 d845399dex992.htm EX-99.2 99084
5 GRAPHIC g845399ex99_3pg015.jpg GRAPHIC 73382
6 GRAPHIC g845399ex99_3pg016.jpg GRAPHIC 70775
7 GRAPHIC g845399ex99_3pg017.jpg GRAPHIC 100820
8 GRAPHIC g845399ex99_3pg018.jpg GRAPHIC 71816
9 GRAPHIC g845399g81s44greyscale.jpg GRAPHIC 154473
10 GRAPHIC g845399g96g59.jpg GRAPHIC 71218
  Complete submission text file 0001193125-15-001785.txt   1185645
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 15505267
SIC: 2834 Pharmaceutical Preparations